In 96 lung squamous cell carcinoma blood samples, there were 8 (8.3%) EGFR mutations, 7 (7.3%) KRAS mutations, 6 (6.3%) PIK3CA mutations and 1 (1.0%) BRAF mutations. This evidence concerns the gene PIK3CA and squamous cell lung carcinoma.